Holen Sie sich die Stockscreener-App
34.51
1.41%
0.48
Handel nachbörslich:
34.80
0.29
+0.84%
Schlusskurs vom Vortag:
$34.03
Offen:
$34
24-Stunden-Volumen:
1.78M
Relative Volume:
1.53
Marktkapitalisierung:
$1.92B
Einnahmen:
$249.12M
Nettoeinkommen (Verlust:
$-90.19M
KGV:
-20.30
EPS:
-1.7
Netto-Cashflow:
$-88.21M
1W Leistung:
-5.06%
1M Leistung:
-4.06%
6M Leistung:
-37.95%
1J Leistung:
-62.61%
1-Tages-Spanne:
$33.38
$34.97
1-Wochen-Bereich:
$33.38
$37.28
52-Wochen-Spanne:
$32.11
$103.81
Procept Biorobotics Corp Stock (PRCT) Company Profile
Firmenname
Procept Biorobotics Corp
Sektor
Branche
Telefon
(650) 232-9832
Adresse
150 BAYTECH DRIVE, SAN JOSE
Vergleichen Sie PRCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
34.51 | 1.89B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-02 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-07-09 | Eingeleitet | Stephens | Overweight |
| 2025-07-07 | Eingeleitet | Oppenheimer | Perform |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Eingeleitet | Jefferies | Hold |
| 2023-08-11 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-31 | Eingeleitet | William Blair | Outperform |
| 2022-10-31 | Eingeleitet | BTIG Research | Neutral |
| 2022-10-25 | Eingeleitet | Truist | Buy |
| 2022-09-02 | Eingeleitet | Wells Fargo | Overweight |
| 2022-07-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Goldman | Neutral |
| 2021-10-11 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Procept Biorobotics Corp Aktie (PRCT) Neueste Nachrichten
Will PROCEPT BioRobotics Corporation stock outperform tech sector in 20252025 Technical Overview & Fast Momentum Entry Tips - newser.com
How to track smart money flows in PROCEPT BioRobotics CorporationEarnings Trend Report & Reliable Entry Point Trade Alerts - newser.com
What hedge fund activity signals for PROCEPT BioRobotics Corporation stock2025 Momentum Check & Fast Moving Stock Watchlists - newser.com
Bessemer Group Inc. Acquires 7,435 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Procept Biorobotics Corp expected to post a loss of 41 cents a shareEarnings Preview - TradingView
Procept Biorobotics’ WATER IV Study: A Game Changer in Prostate Cancer Treatment? - MSN
How institutional ownership impacts PROCEPT BioRobotics Corporation stock2025 Support & Resistance & Risk Controlled Swing Alerts - newser.com
Live market analysis of PROCEPT BioRobotics Corporation2025 Momentum Check & Smart Swing Trading Techniques - newser.com
PROCEPT BioRobotics Corporation (PRCT) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Oppenheimer Upgrades PROCEPT BioRobotics (PRCT) - MSN
Earnings Preview: PROCEPT BioRobotics Corporation (PRCT) Q3 Earnings Expected to Decline - Yahoo Finance
PROCEPT BioRobotics (PRCT) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Procept Biorobotics’ Aquablation Therapy Study: A Potential Game-Changer for Prostate Treatment - TipRanks
Can volume confirm reversal in PROCEPT BioRobotics CorporationMarket Risk Analysis & Weekly High Potential Alerts - newser.com
Using data filters to optimize entry into PROCEPT BioRobotics Corporation2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
How to integrate PROCEPT BioRobotics Corporation into portfolio analysis tools - newser.com
PRCT.MX interactive stock chart | PROCEPT BIOROBOTICS CORP stock - Yahoo! Finance Singapore
Applying chart zones and confluence areas to PROCEPT BioRobotics CorporationEarnings Risk Summary & Low Drawdown Trading Strategies - newser.com
Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares? - sharewise.com
Truist Lowers PT on PROCEPT BioRobotics Corporation (PRCT) to $50 From $64, Keeps a Buy Rating - Insider Monkey
What drives PROCEPT BioRobotics Corporation stock priceSector Rotation Strategies & Our Experts Decode Market Noise for You - earlytimes.in
Finanzdaten der Procept Biorobotics Corp-Aktie (PRCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.84%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):